Document:

Exhibit 4.1       Form of Warrant

 THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE
      NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR
  APPLICABLE STATE SECURITIES LAWS. THIS WARRANT AND THE COMMON SHARES ISSUABLE
   UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR
            HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION
        STATEMENT AS TO THIS WARRANT UNDER SAID ACT AND APPLICABLE STATE
               SECURITIES LAWS OR AN OPINION OF COUNSEL REASONABLY
             SATISFACTORY TO MEDIVISOR, INC. THAT SUCH REGISTRATION
                                IS NOT REQUIRED.

      Right to Purchase 1,000,000 Shares of Common Stock of Medivisor, Inc.
                   subject to adjustment as provided herein)

                          COMMON STOCK PURCHASE WARRANT

No. ___                                     Issue Date: as of              2004

         Medivisor, Inc., a corporation organized under the laws of the State of
Delaware (the "Company"), hereby certifies that, for value received,
______________________________ or permissible assigns, is entitled, subject to
the terms set forth below, to purchase from the Company after the Issue Date at
any time or in compliance with Rule 415(a)(1)(ix), at a price of $1.25 per share
for the duration of the Offering by the Company before 5:00 p.m., New York time,
on , 2005 (the "Expiration Date"), up to _________ fully paid and non-assessable
shares of Common Stock (as hereinafter defined), $.001 par value per share, of
the Company, at a purchase price of $1.25 per share of Common Stock (such
purchase price per share as adjusted in compliance with Rule 415(a)(1)(ix), at a
price of $1.25 per share for the duration of the Offering by the Company as
herein provided is referred to herein as the "Purchase Price"). The number and
character of such shares of Common Stock and the Purchase Price are subject to
adjustment as provided herein.

         As used herein the following terms, unless the context otherwise
requires, have the following respective meanings:

         (a) The term Company shall include Medivisor, Inc. and any corporation,
         which shall succeed or assume the obligations of Medivisor, Inc.
         hereunder.

         (b) The term "Common Stock" includes (a) the Company's Common Stock,
         $.001 par value per share, as authorized on the date of the Agreement,
         (b) any other capital stock of any class or classes (however
         designated) of the Company, authorized on or after such date, the
         holders of which shall have the right, without limitation as to amount,
         either to all or to a share of the balance of current dividends and

                                       1
<PAGE>

         liquidating dividends after the payment of dividends and distributions
         on any shares entitled to preference, and the holders of which shall
         ordinarily, in the absence of contingencies, be entitled to vote for
         the election of a majority of directors of the Company (even if the
         right so to vote has been suspended by the happening of such a
         contingency) and (c) any other securities into which or for which any
         of the securities described in (a) or (b) may be converted or exchanged
         pursuant to a plan of recapitalization, reorganization, merger, sale of
         assets or otherwise.

         (c) The term "Other Securities" refers to any stock (other than Common
         Stock) and other securities of the Company or any other person
         (corporate or otherwise) which the holder of the Warrant at any time
         shall be entitled to receive, or shall have received, on the exercise
         of the Warrant, in lieu of or in addition to Common Stock, or which at
         any time shall be issuable or shall have been issued in exchange for or
         in replacement of Common Stock or Other Securities pursuant to Section
         5 or otherwise.

1. Exercise of Warrant.

         1.1. Number of Shares issuable upon Exercise. From and after the date
hereof through and including the Expiration Date, the holder hereof shall be
entitled to receive, upon exercise of this Warrant in whole in accordance with
the terms of subsection 1.2 or upon exercise of this Warrant in part in
accordance with subsection 1.3, the number of shares of Common Stock of the
Company identified on Page 1 hereof, subject to adjustment pursuant to Section
4.

         1.2. Full Exercise. This Warrant may be exercised in full by the holder
hereof by surrender of this Warrant, with the form of subscription attached as
Exhibit A hereto (the "Subscription Form") duly executed by such holder, to the
Company at its principal office or at the office of its Warrant agent (as
provided in Section 11), accompanied by payment, in cash or by certified or
official bank check payable to the order of the Company, in the amount obtained
by multiplying the number of shares of Common Stock for which this Warrant is
then exercisable by the Purchase Price (as hereinafter defined) then in effect.

         1.3. Partial Exercise. This Warrant may be exercised in part (but not
for a fractional share) by surrender of this Warrant in the manner and at the
place provided in subsection 1.2 except that the amount payable by the holder on
such partial exercise shall be the amount obtained by multiplying (a) the number
of shares of Common Stock designated by the holder in the Subscription Form by
(b) the Purchase Price. On any such partial exercise, the Company, at its
expense, will forthwith issue and deliver to or upon the order of the holder
hereof a new Warrant of like tenor, in the name of the holder hereof or as such
holder (upon payment by such holder of any applicable transfer taxes), may
request, the number of shares of Common Stock for which such Warrant may still
be exercised.

         1.4. Fair Market Value. Fair Market Value of a share of Common Stock as
of a particular date (the "Determination Date") shall mean the Fair Market Value
of a share of the Company's Common Stock. Fair Market Value of a share of Common
Stock as of a Determination Date shall mean:

                                       2
<PAGE>

         (a) If the Company's Common Stock is traded on an exchange or is quoted
         on the National Association of Securities Dealers, Inc. Automated
         Quotation ("NASDAQ") National Market System or the NASDAQ SmallCap
         Market, then the closing or last sale price, respectively, reported for
         the last business day immediately preceding the Determination Date.

         (b) If the Company's Common Stock is not traded on an exchange or on
         the NASDAQ National Market System or the NASDAQ SmallCap Market but is
         traded in the over-the-counter market, then the mean of the closing bid
         and asked prices reported for the last business day immediately
         preceding the Determination Date.

         (c) Except as provided in clause (d) below, if the Company's Common
         Stock is not publicly traded, then as the Holder and the Company agree
         or in the absence of agreement by arbitration in accordance with the
         rules then standing of the American Arbitration Association, before a
         single arbitrator to be chosen from a panel of persons qualified by
         education and training to pass on the matter to be decided.

         (d) If the Determination Date is the date of a liquidation, dissolution
         or winding up, or any event deemed to be a liquidation, dissolution or
         winding up pursuant to the Company's charter, then all amounts to be
         payable per share to holders of the Common Stock pursuant to the
         charter in the event of such liquidation, dissolution or winding up,
         plus all other amounts to be payable per share in respect of the Common
         Stock in liquidation under the charter, assuming for the purposes of
         this clause (d) that all of the shares of Common Stock then issuable
         upon exercise of all of the Warrants are outstanding at the
         Determination Date.

         1.5. Company Acknowledgment. The Company will, at the time of the
exercise of the Warrant, upon the request of the holder hereof acknowledge in
writing its continuing obligation to afford to such holder any rights to which
such holder shall continue to be entitled after such exercise in accordance with
the provisions of this Warrant. If the holder shall fail to make any such
request, such failure shall not affect the continuing obligation of the Company
to afford to such holder any such rights.

         1.6. Trustee for Warrant Holders. In the event that a bank or trust
company shall have been appointed as trustee for the holders of the Warrants
pursuant to Subsection 3.1, such bank or trust company shall have all the powers
and duties of a warrant agent appointed pursuant to Section 10 and shall accept,
in its own name for the account of the Company or such successor person as may
be entitled thereto, all amounts otherwise payable to the Company or such
successor, as the case may be, on exercise of this Warrant pursuant to this
Section 1.

         2. Delivery of Stock Certificates, etc. on Exercise. The Company agrees
that the shares of Common Stock purchased upon exercise of this Warrant shall be
deemed to be issued to the holder hereof as the record owner of such shares as
of the close of business on the date on which this Warrant shall have been
surrendered and payment made for such shares as aforesaid. As soon as
practicable after the exercise of this Warrant in full or in part, and in any
event within 10 days thereafter, the Company at its expense (including the

                                       3
<PAGE>

payment by it of any applicable issue taxes) will cause to be issued in the name
of and delivered to the holder hereof, or as such holder (upon payment by such
holder of any applicable transfer taxes) may direct, a certificate or
certificates for the number of duly and validly issued, fully paid and
non-assessable shares of Common Stock (or Other Securities) to which such holder
shall be entitled on such exercise, plus, in lieu of any fractional share to
which such holder would otherwise be entitled, cash equal to such fraction
multiplied by the then Fair Market Value of one full share, together with any
other stock or other securities and property (including cash, where applicable)
to which such holder is entitled upon such exercise pursuant to Section 1 or
otherwise.

3. Adjustment for Reorganization, Consolidation, Merger, etc.

         3.1. Reorganization, Consolidation, Merger, etc. In case at any time or
in compliance with Rule 415(a)(1)(ix), at a price of $1.25 per share for the
duration of the Offering by the Company, the Company shall (a) effect a
reorganization, (b) consolidate with or merge into any other person, or (c)
transfer all or substantially all of its properties or assets to any other
person under any plan or arrangement contemplating the dissolution of the
Company, then, in each such case, as a condition to the consummation of such a
transaction, proper and adequate provision shall be made by the Company whereby
the holder of this Warrant, on the exercise hereof as provided in Section 1 at
any time after the consummation of such reorganization, consolidation or merger
or the effective date of such dissolution, as the case may be, shall receive, in
lieu of the Common Stock (or Other Securities) issuable on such exercise prior
to such consummation or such effective date, the stock and other securities and
property (including cash) to which such holder would have been entitled upon
such consummation or in connection with such dissolution, as the case may be, if
such holder had so exercised this Warrant, immediately prior thereto, all
subject to further adjustment thereafter as provided in Section 5.

         3.2. Dissolution. In the event of any dissolution of the Company
following the transfer of all or substantially all of its properties or assets,
the Company, prior to such dissolution, shall at its expense deliver or cause to
be delivered the stock and other securities and property (including cash, where
applicable) receivable by the holders of the Warrants, if exercised, after the
effective date of such dissolution pursuant to this Section 3 to a bank or trust
company having its principal office in New York, NY, as trustee for the holder
or holders of the Warrants.

         3.3. Continuation of Terms. Upon any reorganization, consolidation,
merger or transfer (and any dissolution following any transfer) referred to in
this Section 3, this Warrant shall continue in full force and effect and the
terms hereof shall be applicable to the shares of stock and other securities and
property receivable on the exercise of this Warrant after the consummation of
such reorganization, consolidation or merger or the effective date of
dissolution following any such transfer, as the case may be, and shall be
binding upon the issuer of any such stock or other securities, including, in the
case of any such transfer, the person acquiring all or substantially all of the
properties or assets of the Company, whether or not such person shall have
expressly assumed the terms of this Warrant as provided in Section 5.

         4. Extraordinary Events Regarding Common Stock. In the event that the
Company shall (a) issue additional shares of the Common Stock as a dividend or
other distribution on outstanding Common Stock, (b) subdivide its outstanding
shares of Common Stock, or (c) combine its outstanding shares of the Common

                                       4
<PAGE>

Stock into a smaller number of shares of the Common Stock, then, in each such
event, the Purchase Price shall, simultaneously with the happening of such
event, be adjusted by multiplying the then Purchase Price by a fraction, the
numerator of which shall be the number of shares of Common Stock outstanding
immediately prior to such event and the denominator of which shall be the number
of shares of Common Stock outstanding immediately after such event, and the
product so obtained shall thereafter be the Purchase Price then in effect. The
Purchase Price, as so adjusted, shall be readjusted in the same manner upon the
happening of any successive event or events described herein in this Section 4.
The number of shares of Common Stock that the holder of this Warrant shall
thereafter, on the exercise hereof as provided in Section 1, be entitled to
receive shall be increased to a number determined by multiplying the number of
shares of Common Stock that would otherwise (but for the provisions of this
Section 4) be issuable on such exercise by a fraction of which (a) the numerator
is the Purchase Price that would otherwise (but for the provisions of this
Section 4) be in effect, and (b) the denominator is the Purchase Price in effect
on the date of such exercise.

         5. Chief Financial Officer's Certificate as to Adjustments. In each
case of any adjustment or readjustment in the shares of Common Stock (or Other
Securities) issuable on the exercise of the Warrants, the Company at its expense
will promptly cause its Chief Financial Officer to compute such adjustment or
readjustment in accordance with the terms of the Warrant and prepare a
certificate setting forth such adjustment or readjustment and showing in detail
the facts upon which such adjustment or readjustment is based, including a
statement of (a) the consideration received or receivable by the Company for any
additional shares of Common Stock (or Other Securities) issued or sold or deemed
to have been issued or sold, (b) the number of shares of Common Stock (or Other
Securities) outstanding or deemed to be outstanding, and (c) the Purchase Price
and the number of shares of Common Stock to be received upon exercise of this
Warrant, in effect immediately prior to such adjustment or readjustment and as
adjusted or readjusted as provided in this Warrant. The Company will forthwith
mail a copy of each such certificate to the holder of the Warrant and any
Warrant agent of the Company (appointed pursuant to Section 10 hereof).

         6. Reservation of Stock, etc. Issuable on Exercise of Warrant;
Financial Statements. The Company will at all times reserve and keep available,
solely for issuance and delivery on the exercise of the Warrants, all shares of
Common Stock (or Other Securities) in compliance with Rule 415(a)(1)(ix), at a
price of $1.25 per share for the duration of the Offering by the Company
issuable on the exercise of the Warrant. This Warrant entitles the holder hereof
to receive copies of all financial and other information distributed or required
to be distributed to the holders of the Company's Common Stock.

         7. Assignment; Exchange of Warrant. Subject to compliance with
applicable Securities laws, and delivery of such representations and warranties
as shall reasonably be requested by the Company, this Warrant, and the rights
evidenced hereby, may be transferred by any registered holder hereof (a
"Transferor") with respect to any or all of the Shares. On the surrender for
exchange of this Warrant, with the Transferor's endorsement in the form of
Exhibit B attached hereto (the Transferor Endorsement Form"), to the Company,
the Company at its expense but with payment by the Transferor of any applicable

                                       5
<PAGE>

transfer taxes) will issue and deliver to or on the order of the Transferor
thereof a new Warrant or Warrants of like tenor, in the name of the Transferor
and/or the transferee(s) specified in such Transferor Endorsement Form (each a
"Transferee"), calling in the aggregate on the face or faces thereof for the
number of shares of Common Stock called for on the face or faces of the Warrant
so surrendered by the Transferor.

         8. Replacement of Warrant. On receipt of evidence reasonably
satisfactory to the Company of the loss, theft, destruction or mutilation of
this Warrant and, in the case of any such loss, theft or destruction of this
Warrant, on delivery of an indemnity agreement or security reasonably
satisfactory in form and amount to the Company or, in the case of any such
mutilation, on surrender and cancellation of this Warrant, the Company at its
expense will execute and deliver, in lieu thereof, a new Warrant of like tenor.

         9. Registration Rights. The holder of this Warrant has been granted
certain registration rights by the Company. These registration rights are set
forth in a Subscription Agreement entered into by the initial holder of this
Warrant and the Company in connection with the purchase of the Unit of which
this Warrant is a part. The terms of the Subscription Agreement and Registration
Rights Agreement referred to therein are incorporated herein by this reference.

         10. Warrant Agent. The Company may, by written notice to the each
holder of the Warrant, appoint an agent having an office in New York, NY for the
purpose of issuing Common Stock (or Other Securities) on the exercise of this
Warrant pursuant to Section 1, exchanging this Warrant pursuant to Section 7,
and replacing this Warrant pursuant to Section 8, or any of the foregoing, and
thereafter any such issuance, exchange or replacement, as the case may be, shall
be made at such office by such agent.

         11. Transfer on the Company's Books. Until this Warrant is transferred
on the books of the Company, the Company may treat the registered holder hereof
as the absolute owner hereof for all purposes, notwithstanding any notice to the
contrary.

         12. Call Option. The Company shall have the option to "call" the
Warrants (the "Warrant Call"), in accordance with and governed by the following:

         (a) The Company shall exercise the Warrant Call by giving to each
Warrant Holder a written notice of call (the "Call Notice") at any time prior to
the Expiration Date.

         (b) The Warrant Holders shall exercise their Warrant rights and
purchase the appropriate number of shares of Common Stock and pay for same all
within 10 business days of the date of the Call Notice. Any Warrants which are
Called and not exercised during such 10 business day period shall thereafter not
be exercisable.

         13. Notices, etc. All notices and other communications from the Company
to the holder of this Warrant shall be mailed by first class registered or
certified mail, postage prepaid, at such address as may have been furnished to
the Company in writing by such holder or, until any such holder furnishes to the
Company an address, then to, and at the address of, the last holder of this
Warrant who has so furnished an address to the Company.

                                       6
<PAGE>

         14. Miscellaneous. This Warrant and any term hereof may be changed,
waived, discharged or terminated only by an instrument in writing signed by the
party against which enforcement of such change, waiver, discharge or termination
is sought. This Warrant shall be construed and enforced in accordance with and
governed by the laws of New York. Any dispute relating to this Warrant shall be
adjudicated in New York State. The headings in this Warrant are for purposes of
reference only, and shall not limit or otherwise affect any of the terms hereof.
The invalidity or unenforceability of any provision hereof shall in no way
affect the validity or enforceability of any other provision.

         IN WITNESS WHEREOF, the Company has executed this Warrant under seal as
of the date first written above.

                                 Medivisor, Inc.

                                 By:_______________________________
                                 Title:____________________________

Witness:

--------------------------

                                       7
<PAGE>

                                    EXHIBIT A

                              FORM OF SUBSCRIPTION
                   (To be signed only on exercise of Warrant)

TO:         Medivisor, Inc.

The undersigned, the holder of the within Warrant, hereby irrevocably elects to
exercise this Warrant for, and to purchase there under, shares of Common Stock
of Medivisor, Inc. and herewith makes payment of $ therefore, and requests that
the certificates for such shares be issued in the name of, and delivered to
whose address is

-------------------------------------------------------.

Dated:___________________

                                   ---------------------------------------------
                                   (Signature must conform to name of holder as
                                   specified on the face of the Warrant)

                                   ---------------------------------------------
                                   (Address)

                                       8
<PAGE>

                                    EXHIBIT B

FORM OF TRANSFEROR ENDORSEMENT
(To be signed only on transfer of Warrant)

         For value received, the undersigned hereby sells, assigns, and
transfers unto the person(s) named below under the heading "Transferees" the
right represented by the within Warrant to purchase the percentage and number of
shares of Common Stock of Medivisor, Inc. to which the within Warrant relates
specified under the headings "Percentage Transferred" and "Number Transferred,"
respectively, opposite the name(s) of such person(s) and appoints each such
person Attorney to transfer its respective right on the books of Medivisor, Inc.
with full power of substitution in the premises.

================================================================================
Transferees                Percentage                Number
                           Transferred               Transferred
--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

================================================================================

Dated:            , 200_            _______________________________
                                            (Signature must conform to name of
                                            holder as specified on the face of
                                            the warrant)

Signed in the presence of:

---------------------------       ---------------------------------
         (Name)                   (address)

                                  ---------------------------------
                                  (address)

ACCEPTED AND AGREED:
[TRANSFEREE]

---------------------------
         (Name)

                                       9Exhibit 10.2      Statement of Work with Pfizer Oncology eDetailing Program

                                 MEDIVISOR LOGO
                          The e-detailing solution...

                                                                January 25, 2005

STATEMENT OF WORK

Pfizer Oncology eDetailing Program:

Medivisor, Inc. agrees to provide the following services to Pfizer
Pharmaceuticals Oncology Division. This project will involve a preliminary pilot
program to be followed (provisionally) by two additional similar programs. The
brands to be covered are Camptosar, Aromasin and Ellence.

         o        Medivisor will closely coordinate its efforts on this project
                  with the other project vendors as identified by the program
                  coordinator. Wayne Wertheim will be appointed to interact on
                  Medivisor's behalf and partake as is necessary in all project
                  meetings, conference calls, reviews, etc.

         o        Medivisor will produce (for each brand) an animated (flash
                  type) presentation of approximately 5-9 minutes. This
                  presentation will be constructed using content supplied to
                  Medivisor by the brand agency of record on the project. Once
                  completed the presentation will be hosted on Mednet.

         o        Medivisor will provide its expertise in the formatting,
                  presentation, and execution of the programs, and will
                  coordinate all of the content, flash, and other related items
                  into its final presentation form.

         o        Medivisor will comply with presentation format requirements as
                  set forth by the Mednet agency of record.

         o        Medivisor will produce both a "hand-out" and email invitation
                  to the program. Separate brand specific invitations will be
                  produced for Camptosar, Aromasin and Ellence. Sufficient
                  quantities of the same will be provided to Pfizer for
                  distribution.

         o        Medivisor will provide all documentation necessary to fulfill
                  regulatory compliance in accordance will Pfizer policies.

                                       1
<PAGE>

PROGRAM PRICE: $50 - 60,000

(Note: Pricing is for all three brand projects. Each project will be billed per
brand project at a rate of 1/3 the total program price.)

TERMS: 50% due at acceptance of this document, balance due upon delivery of
       Final product.

Accepted: __________________________________  Date: ____________________________
           Kelly Shen -Director Business Technology/ Program Coordinator
 Pfizer Pharmaceuticals

Accepted: __________________________________  Date: ____________________________
           Wayne H. Wertheim
           Executive VP, Medivisor, Inc.

                                       2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00084-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00084-of-00352.parquet"}]]